The first cannabis exchange-traded fund (ETF) launched in 2017, and we have been following the developments closely since then. Today, we are tracking 11 ETFs. We recently shared a review of these funds with subscribers to our premium cannabis due diligence service 420 Investor, concluding that there has been a substantial evolution over the past four years, though few of the ETFs have been able to scale. Further, performance relative to benchmarks hasn’t been particularly strong. Some ETFs don’t have benchmarks, which we believe does a disservice to investors who deserve accountability. There are now 4 cannabis ETFs that have grown to assets in excess of $100 million, including AdvisorShares Pure US Cannabis ETF (NYSE ARCA: MSOS), ETFMG Alternative Harvest ETF (NYSE ARCA: MJ), Horizons Marijuana Life Sciences ETF (TSX: HMMJ) and AdvisorShares Pure Cannabis ETF (NYSE ARCA: YOLO).
New Cannabis Ventures, 03/20/2022 11:05:00
Open article: https://www.newcannabisventures.com/cannabis-etfs-evolve-but-dont-yet-excel/